• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


Prices delayed by at least 15 minutes | Print

Live UK pricing:

Scancell Holdings PLC (SCLP)

ORD 0.1P
Sell: 12.00p|Buy: 13.00p|Change: 0.19 (1.52%)

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment

Company profile

Scancell Holdings PLC is a clinical-stage biotechnology company developing targeted off-the-shelf active immunotherapies to generate safe and long-lasting tumour-specific immunity for a cancer-free future. iSCIB1+, a product from its DNA ImmunoBody platform (AvidiMab), has demonstrated safe, durable, and clinically meaningful benefit as a monotherapy as well as additional benefit when combined with checkpoint therapies in an ongoing Phase 2 trial in melanoma. Modi-1, the peptide immunotherapy from its Moditope platform, is being investigated in a Phase 2 study in a broad range of solid tumours. In addition, the company has established a subsidiary with the intention to hold and develop an early-stage pipeline of high-affinity GlyMab antibodies targeting tumour-specific glycans.

Address

Robert Robinson Avenue
John Eccles House, Oxford Science Park
Oxford
GBR
OX4 4GP

Telephone

+44 1865338069

Website

https://www.scancell.co.uk

Sector 

Healthcare

Forecast key dates

NameKey Date
Scancell Holdings PLC Second Quarter Earnings Conference Call for 20272027-01-29T14:00:00
Scancell Holdings PLC Second Quarter Earnings Results for 20272027-01-29T00:00:00
Scancell Holdings PLC Annual General Meeting for 20262026-10-30T15:00:00
Scancell Holdings PLC Fourth Quarter Earnings Conference Call for 20262026-09-11T12:00:00
Scancell Holdings PLC Fourth Quarter Earnings Results for 20262026-09-11T00:00:00
Scancell Holdings PLC Annual Report for 20262026-09-11T00:00:00

Previous key dates

NameKey Date
Scancell Holdings PLC Second Quarter Earnings Conference Call for 20262026-01-29T14:00:00
Scancell Holdings PLC Second Quarter Earnings Result for 20262026-01-29T00:00:00
Scancell Holdings PLC Annual General Meeting for 20252025-10-30T15:00:00
Scancell Holdings PLC Fourth Quarter Earnings Conference Call for 20252025-09-11T12:00:00
Scancell Holdings PLC Fourth Quarter Earnings Result for 20252025-09-11T00:00:00
Scancell Holdings PLC Annual Report for 20252025-09-11T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.